← 홈

IBD (크론·대장) · TNF-α

57개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 57개
AntibodystaleJanssenApproved

Infliximab-Innovator (Infliximab-Innovator)

Colitis, Ulcerative; Crohn's Disease · Colitis, Ulcerative

#ColitisUlcerative#Antibody#Approved#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAsan Medical CenterApproved

Standard infliximab intravenous therapy (Standard infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleAbbVieApproved

adalimumab (Humira, Standard-Dose Adalimumab)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Standard-Dose infliximab (Standard-Dose infliximab)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAsan Medical CenterApproved

TDM-based infliximab intravenous therapy (TDM-based infliximab intravenous therapy)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleUniversity of CalgaryApproved

adalimumab (Humira, TNFa Antagonist - Adalimumab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleUniversity of CalgaryApproved

TNFa Antagonist - Infliximab (TNFa Antagonist - Infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRabin Medical CenterPreclinical

adalimumab (Humira, Treatment with Adalimumab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleAbbViePreclinical

ustekinumab (Stelara, adalimumab, infliximab, ustekinumab, golimumab, and vedolizumab)

Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) · Inflamatory Bowel Disease (Crohn's a

#InflamatoryBowelDiseaseCrohn39sa#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAbbViePhase 3

adalimumab (Humira, azathioprine or adalimumab and infliximab)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

adalimumab (Humira, infliximab and adalimumab)

Crohn's Disease; Ulcerative Colitis · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 0 (infliximab and azathioprine combination at week 0)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 14 (infliximab and azathioprine combination at week 14)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

infliximab therapeutic drug monitoring (infliximab therapeutic drug monitoring)

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

ustekinumab (Stelara, infliximab, adalimumab, golimumab, vedolizumab, ustekinumab)

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE

3 / 3 페이지

← 이전다음 →